Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2012
03/15/2012US20120064542 Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid
03/15/2012US20120064541 N-glycan core beta-galactosyltransferase and uses thereof
03/15/2012US20120064533 assay for detecting vitamin d and antibodies therefor
03/15/2012US20120064096 BTLA Antibodies and Uses Thereof
03/15/2012US20120064093 Antibody
03/15/2012US20120064090 Therapeutic agent for cancer having reduced sensitivity to molecular target drug and pharmaceutical composition for enhancing sensitivity to molecular target drug
03/15/2012US20120064084 Signal transduction protein tab2
03/15/2012US20120064083 Therapeutic use of anti-cs1 antibodies
03/15/2012US20120064082 Aminoacyl trna synthetases for modulating hematopoiesis
03/15/2012US20120064081 Anti-kir3d antibodies
03/15/2012US20120064080 Human LY6-Big Molecules and Methods of Use
03/15/2012US20120064079 Compositions and Methods for Preventing Erythropoietin-Associated Hypertension
03/15/2012US20120064077 Stable and soluble antibodies inhibiting tnf alpha
03/15/2012US20120064074 Antigen binding domains
03/15/2012US20120064069 Therapeutic use of anti-cs1 antibodies
03/15/2012US20120064068 Therapeutic use of anti-cs1 antibodies
03/15/2012US20120064067 Therapeutic use of anti-cs1 antibodies
03/15/2012US20120064066 Monoclonal Antibodies to Hepatocyte Growth Factor
03/15/2012US20120064065 Safe and functional humanized antibodies
03/15/2012US20120064064 Antigen-binding proteins
03/15/2012US20120064063 Compositions of F(ab')2 Antibody Fragments
03/15/2012US20120064037 Methods For Treating Diseases and HCV Using Antibodies To Aminophospholipids
03/15/2012US20120064002 Enantiomer-pure (4S,8S)- and (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triaza-3N,6N,9N-tricarboxymethyl-1,11-undecanedioic Acid and Derivatives Thereof, Process for their Production and Use for the Production of Pharmaceutical Agents
03/15/2012US20120064000 Human Monoclonal Antibodies Against Hendra And Nipah Viruses
03/15/2012US20120063999 Psca: prostate stem cell antigen and uses thereof
03/15/2012US20120063998 Method for Treating Psoriatic Arthritis by Administering an Anti-IL-12 Antibody
03/15/2012US20120063993 Therapeutic and diagnostic conjugates for use with multispecific antibodies
03/15/2012US20120063954 Adsorbents for the adsorption of hepcidin
03/15/2012CA2810770A1 Methods and kits for the detection of an infection in subjects with low specific antibody levels
03/15/2012CA2810668A1 Methods for assessing and identifying or evolving conditionally active therapeutic proteins
03/15/2012CA2810359A1 4-1bb binding molecules
03/15/2012CA2809375A1 Anti-vegfr-3 antibody compositions
03/14/2012EP2428522A1 Antibodies that bind to PSCA proteins for diagnosis of cancer
03/14/2012EP2428521A1 Antibodies that recognize sulphatides and sulphated proteoglycans and the use thereof
03/14/2012EP2428252A1 Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo
03/14/2012EP2428226A1 Antibody targeting compounds
03/14/2012EP2428225A2 Use of human cells of myeloid leukaemia origin for expression of antibodies
03/14/2012EP2428224A2 Use of human cells of myeloid leukaemia origin for expression of antibodies
03/14/2012EP2428223A2 Use of human cells of myeloid leukaemia origin for expression of antibodies
03/14/2012EP2428221A1 Dengue vaccine, pharmaceutical composition comprising the same, nucleotide molecule and antibody composition
03/14/2012EP2428216A2 Methods of treating cancer using IL-21 and monoclonal antibody therapy
03/14/2012EP2427497A2 Use of igg1 immunoglobulins and/or ligands of the cd32 receptor for treating inflammatory diseases and incidents via the mucosa
03/14/2012EP2427496A1 Anti-vegf-d antibodies
03/14/2012EP2427495A1 Treatment for multiple sclerosis
03/14/2012EP2427494A1 Diagnostic biomarkers for fibrotic disorders
03/14/2012EP2427493A1 Humanized anti-egfl7 antibodies and methods using same
03/14/2012EP2427492A1 Biomarker antibody and diagnosis device for detecting certain autoimmune diseases
03/14/2012EP2427491A2 Compositions and methods for antibodies targeting complement protein c3b
03/14/2012EP2427490A1 Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
03/14/2012EP2427489A1 Method of controlling o-linked glycosylation of antibodies
03/14/2012EP2427488A1 Method of controlling o-linked glycosylation of antibodies
03/14/2012EP2427479A2 Antibodies and methods of use thereof
03/14/2012EP2427212A2 Anti-cd100 antibodies and methods for using the same
03/14/2012EP2427211A1 Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
03/14/2012EP2427210A1 Modulation of inducible nitric oxide (inos) binding to spry domain-containing socs-box peptides (ssb)
03/14/2012EP2427203A2 Anti-il-17f antibodies and methods of use thereof
03/14/2012EP1910837B1 Methods and compositions for diagnosis and treatment of influenza
03/14/2012EP1888640B1 Improved nanobodies against tumor necrosis factor-alpha
03/14/2012EP1869085B1 Novel anti-plgf antibody
03/14/2012EP1852442B1 Antibody for assay of adamts13 activity and method of activity assay
03/14/2012EP1756577B1 Methods and compositions for the detection of cervical disease
03/14/2012EP1707215B1 Remedy for vasculitis
03/14/2012EP1629009B1 Compositions comprising large and small binding fragments of antibodies against the same toxin
03/14/2012EP1613658B1 Antibodies against insulin-like growth factor i receptor and uses thereof
03/14/2012EP1572946B1 Therapeutic human anti-il-1r1 monoclonal antibody
03/14/2012EP1499729B9 Derivatives of the nf-kappab inducing enzyme, their preparation and use
03/14/2012EP1436003B3 Taci-immunoglobulin fusion proteins
03/14/2012CN1976951B Anti-EpCAM immunoglobulins
03/14/2012CN1558774B Angiotensin peptide-carrier conjugates and uses thereof
03/14/2012CN102378814A Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
03/14/2012CN102378768A Bispecific anti-erbb-3/anti-c-met antibodies
03/14/2012CN102378767A Anti-fgfr3 antibodies and methods using same
03/14/2012CN102378766A Compounds compositions and methods of treating cancer and fibrotic diseases
03/14/2012CN102375065A Identifying Method For Acylation Of Lysine Butane In Protein And Preparation Of Affine Reagent Thereof
03/14/2012CN102373234A Method for purifying recombinant proteins with intein-mediated elastin like proteins
03/14/2012CN102373225A Recombinant protein A efficiently combined with IgG (Immunoglobulin G) and construction method of engineering bacterium thereof
03/14/2012CN102373215A Antigen binding molecules with increased fc receptor binding affinity and effector function
03/14/2012CN102373214A Antigen binding molecules with increased fc receptor binding affinity and effector function
03/14/2012CN102372779A Camel single domain antibody with allinase activity as well as preparation method and application thereof
03/14/2012CN102372778A Anti-human VEGF/anti-OPN bispecific antibody, its preparation method and application
03/14/2012CN102372773A Human bladder cancer tumor marker, antibody thereof and application thereof
03/14/2012CN102372737A Preparation method and application of parathion-methyl artificial hapten, artificial antigen and specific antibody
03/14/2012CN101775371B Anti-testicle-protein hTSC29 antibody or antibody fragment and application thereof
03/14/2012CN101717446B Preparation for PRRSV-N-IgY antibody and application thereof in detecting PRRSV
03/13/2012US8133983 Agonistic binding molecules to the human OX40 receptor
03/13/2012US8133982 FcγRIIB specific antibodies and methods of use thereof
03/13/2012US8133981 Therapeutic use of anti-CS1 antibodies
03/13/2012US8133980 Antibodies and functional fragments thereof that specifically bind an RF-amide peptide or a precursor thereof
03/13/2012US8133979 Antibodies against human angiopoietin 2
03/13/2012US8133978 Humanised anti-interleukin-18 antibody
03/13/2012US8133877 Composition comprising an antisense sequence implicated in the regulation of angiogenesis
03/13/2012US8133873 Recombinant chemokine-antigen vaccine
03/13/2012US8133867 Method for treating rheumatoid arthritis with an antibody that binds to a hepatocyte growth factor receptor
03/13/2012US8133744 Production of antibodies and to medical uses involving antibodies
03/13/2012US8133734 Kit comprising an antibody to interleukin 17 receptor-like protein
03/13/2012US8133709 Target sequences for synthetic molecules
03/13/2012US8133694 Functional vitamin D derivatives and method of determining 25-hydroxy- and 1α, 25-dihydroxy vitamin D
03/13/2012US8133688 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
03/13/2012US8133490 Method and system to remove cytokine inhibitors in patients
03/13/2012US8133488 Methods and compositions for targeting polyubiquitin
1 ... 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 ... 1494